The Human Microbiome—Our Body's Secret Weapon
New research on the role of microbes in fighting disease is transforming the way medicine views bacteria, writes Lee Jones.
Ebola Crisis Challenges Pharma R&D
Companies gain support-and pressure-to deliver new treatments for spreading outbreak.
Gain a Competitive Edge: Think Like a Navy SEAL
Pharmaceutical professionals, teams, and organizations can succeed at an elite level by tackling the tough mental challenges of Navy SEAL training.
Eruptions on the Drug-Pricing Horizon in Europe
An escalating political debate over pharma pricing and reimbursement nears the boiling point.
New Patent-Defense Path for Pharma
Inter Partes Review can potentially offer a more economical and streamlined litigation strategy for pharma and biotech players, writes David Dalke.
The Gate Keeper: Dr. David Haslam, Chair of NICE, UK
NICE's David Haslam discusses the UK drug watchdog's new challenge in meeting expectations around what quantitative calculations of value mean to patient access today.
